Astrazeneca AZN
NYSE AZN
$184.49 +0.12 (+0.07%)
At close: Nov 13, 2026 · 4:00 PM EST

Astrazeneca (AZN) Long-Term Debt Issuances (2009 - 2010)

Updated

Astrazeneca's Long-Term Debt Issuances was $15 million in FY2025, down 99.8% from $6.49 billion in FY2024.

Analysis

Astrazeneca (AZN) Long-Term Debt Issuances (2009 - 2010) Analysis & Trends

From FY2015 onward, Astrazeneca has reported Long-Term Debt Issuances for 10 years.

  • Long-Term Debt Issuances shows a five-year compound annual growth rate of -65.3% (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual Long-Term Debt Issuances in data going back to FY2015.
  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $6.49 billion in FY2024 (+70.1%), $3.82 billion in FY2023 and $12.93 billion in FY2021 (+335.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.98 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -9.22 Bn
Dec 31, 2009 -11.06 Bn
API Access

Astrazeneca Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AZN&period=max&api_key=YOUR_API_KEY